Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Financing Cash Flow

Financing Cash Flow at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$78.5M+90.4%
Alkermes logo
AlkermesALKS
$1.47B+197,292%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$2.99M-89.8%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$84.33M+6,037%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$59.06M-50.8%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$4.23M+130%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s financing cash flow?
Harmony Biosciences Holdings, Inc. (HRMY) reported financing cash flow of -$7.22M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s financing cash flow changed year-over-year?
Harmony Biosciences Holdings, Inc.'s financing cash flow decreased by 1950.6% year-over-year, from -$352K to -$7.22M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s financing cash flow?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s financing cash flow has grown at a 4.0% compound annual growth rate (CAGR), from $7.73M to -$9.05M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.